Ecolab

US · ECL #296 by market cap Listed 1970

278.10 -2.72 -0.97%

Live - 5344 symbols - heartbeat 66s ago · 2026-10-08 06:09

Pre-market 279.00 +0.32%

After-hours 278.10 0.00%

Market cap: 77.96B
P/E (TTM): 37.33
P/B: 7.75
EPS: 7.28
Div yield: 1.02%
52W pos: 56%

Reader sentiment Are you bullish or bearish on ECL?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 4.93, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +2.16% YoY

Margins

Gross margin: 44.46%
Operating margin: 17.99%
Net margin: 12.91%

Key ratios & quality

Enterprise value: 85.71B
PEG ratio: 1.56
Altman Z-Score: 4.93

PEG uses trailing P/E against the 3-year net income growth rate (23.88%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	12.22B	12.56B	11.79B	12.73B	14.19B	15.32B	15.74B	16.08B
Gross profit	5.35B	5.52B	4.88B	5.12B	5.36B	6.17B	6.84B	7.15B
Selling & admin expenses	3.51B	3.55B	3.31B	3.42B	3.65B	4.06B	4.23B	4.26B
Research & development	--	--	--	--	--	--	--	--
Operating profit	1.84B	1.97B	1.58B	1.70B	1.70B	2.10B	2.61B	2.89B
Pretax profit	1.59B	1.73B	1.16B	1.41B	1.34B	1.76B	2.57B	2.55B
Tax	321.20M	288.60M	176.60M	270.20M	234.50M	362.50M	439.30M	454.60M
Net profit	1.44B	1.58B	-1.19B	1.14B	1.11B	1.39B	2.13B	2.09B
Basic EPS	5	5	-4	4	4	5	7	7
Diluted EPS	4.88	5.33	-4.20	3.91	3.81	4.79	7.37	7.28

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	3.70B	4.03B	4.17B	4.20B	4.07B	4.42B
Gross profit	1.63B	1.80B	1.87B	1.85B	1.77B	1.95B
Selling & admin expenses	1.05B	1.07B	1.08B	1.06B	1.10B	1.14B
Research & development	--	--	--	--	--	--
Operating profit	584.80M	734.70M	786.40M	786.60M	668.40M	804.30M
Pretax profit	510.00M	659.90M	717.70M	660.30M	558.10M	693.60M
Tax	103.50M	131.40M	128.00M	91.70M	121.50M	154.90M
Net profit	406.50M	528.50M	589.70M	568.60M	436.60M	538.70M
Basic EPS	1	2	2	2	2	2
Diluted EPS	1.41	1.84	2.05	1.98	1.52	1.90

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	4.68B	4.83B	5.12B	4.69B	5.49B	5.64B	6.03B	5.96B
Cash & ST investments	114.70M	118.80M	1.26B	359.90M	598.60M	919.50M	1.26B	646.20M
Inventory	1.55B	1.08B	1.29B	1.49B	1.79B	1.50B	1.46B	1.49B
Total assets	20.07B	20.87B	18.13B	21.21B	21.46B	21.85B	22.39B	24.70B
Total current liabilities	3.69B	3.63B	2.93B	3.55B	4.21B	4.35B	4.79B	5.53B
Short-term debt	743.60M	502.70M	142.90M	526.10M	613.40M	756.50M	758.00M	1.04B
Long-term debt	6.30B	5.97B	6.67B	8.35B	8.08B	7.55B	6.95B	7.37B
Total liabilities	12,020,900,000.00	12,143,300,000.00	11,924,500,000.00	13,953,300,000.00	14,205,700,000.00	13,774,400,000.00	13,598,600,000.00	14,891,800,000.00
Total equity	8.05B	8.73B	6.20B	7.25B	7.26B	8.07B	8.79B	9.80B
Retained earnings	8.91B	9.99B	8.24B	8.81B	9.32B	10.08B	11.52B	12.83B

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	6.08B	7.08B	7.11B	5.96B	6.04B	11.02B
Cash & ST investments	1.16B	1.92B	1.96B	646.20M	519.80M	5.14B
Inventory	1.55B	1.57B	1.53B	1.49B	1.57B	1.64B
Total assets	22.37B	23.74B	23.90B	24.70B	25.04B	29.93B
Total current liabilities	4.61B	4.91B	4.19B	5.53B	6.10B	5.99B
Short-term debt	761.50M	844.60M	176.50M	1.04B	1.74B	1.44B
Long-term debt	7.00B	7.52B	8.05B	7.37B	6.92B	11.91B
Total liabilities	13,462,700,000.00	14,385,400,000.00	14,143,700,000.00	14,891,800,000.00	15,008,600,000.00	19,842,600,000.00
Total equity	8.90B	9.35B	9.75B	9.80B	10.03B	10.08B
Retained earnings	11.74B	12.08B	12.48B	12.83B	13.06B	13.39B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	2.28B	2.42B	1.86B	2.06B	1.79B	2.41B	2.81B	2.95B
Depreciation & amortization	730.40M	775.30M	812.70M	843.10M	938.70M	923.60M	935.40M	976.40M
Free cash flow	1.50B	1.69B	1.37B	1.42B	1.08B	1.64B	1.82B	1.90B
Dividends paid	-494.80M	-552.90M	-560.80M	-566.40M	-602.80M	-617.30M	-664.30M	-753.60M
Stock buybacks / issuance	-562.40M	-353.70M	-146.20M	-106.60M	-518.20M	-13.70M	-986.50M	-783.80M
Ending cash balance	294.00M	186.40M	1.26B	359.90M	598.60M	919.50M	1.26B	646.20M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	369.40M	701.80M	791.30M	1.09B	445.90M	729.50M
Depreciation & amortization	236.10M	241.70M	242.50M	256.10M	263.10M	268.90M
Free cash flow	131.50M	485.10M	529.70M	758.00M	97.40M	489.40M
Dividends paid	-192.00M	-188.00M	-184.40M	-189.20M	-215.90M	-208.20M
Stock buybacks / issuance	-153.70M	-45.50M	-175.40M	-409.20M	-344.40M	-324.90M
Ending cash balance	1.16B	1.92B	1.96B	646.20M	519.80M	5.14B

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	18.30	18.68	-16.23	16.88	15.10	17.96	25.14	22.40
ROA %	7.14	7.61	-6.18	5.75	5.12	6.34	9.55	8.82
ROIC %	10.71	11.20	-6.64	8.81	7.92	9.73	13.88	12.70
5-year avg ROE %	17.48	17.94	11.87	11.69	10.55	10.48	11.77	19.50
EBIT margin %	13.92	14.18	12.44	12.92	11.25	13.74	18.50	17.75
FCF / sales %	9.75	10.87	11.63	11.14	7.58	10.69	11.56	11.84
Current ratio	1.27	1.33	1.75	1.32	1.30	1.30	1.26	1.08
Quick ratio	0.79	0.72	1.26	0.84	0.83	0.91	0.89	0.77
Debt / assets	35.10	32.69	39.24	43.18	42.05	39.98	37.00	36.43
LT debt / equity	78.74	72.76	113.03	119.46	116.27	99.16	85.92	81.49
Interest coverage	8.61	9.82	4.81	7.13	6.33	6.03	8.56	9.32
Revenue CAGR (3Y) %	-3.37	-1.52	-5.19	1.37	4.14	9.12	7.33	4.26
Net income CAGR (3Y) %	12.56	8.25	--	-7.53	-11.20	--	23.19	23.88
FCF CAGR (3Y) %	8.16	12.61	3.89	-1.81	-13.97	6.08	8.64	20.97

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	24.62	24.26	21.73	22.40	22.31	21.85
ROA %	9.63	9.45	8.63	8.82	8.88	7.89
ROIC %	13.84	13.49	12.33	12.70	12.68	11.01
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	18.75	19.12	17.14	17.75	17.67	17.53
FCF / sales %	9.58	10.01	9.78	11.84	11.37	11.13
Current ratio	1.32	1.44	1.70	1.08	0.99	1.84
Quick ratio	0.91	1.05	1.26	0.77	0.68	1.50
Debt / assets	37.37	37.78	36.95	36.43	37.01	46.51
LT debt / equity	85.59	87.15	89.04	81.49	75.23	124.13
Interest coverage	9.24	9.56	9.01	9.32	9.35	9.14
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Lead segment, long tail

Global Water is the largest reported line at 50.18% of revenue, across 5 reported segments.
Global Institutional & Specialty follows at 36.63%, so the top line still matters most but isn’t the whole story.

Revenue breakdown most recent period

Business

Global Water50.18%

Global Institutional & Specialty36.63%

Global Pest Elimination7.94%

Global Life Sciences5.01%

Effect of foreign currency translation0.25%

Quote time 2026-10-08 06:09:36 · For reference only, not investment advice and not tailored to your situation.